Founded in South San Francisco, Profusa is dedicated to transforming health and wellness by making the body’s chemistry easily accessible. The company focuses on pioneering tissue-integrating biosensors for continuous monitoring of body chemistries. Their flagship product, the Lumee® Oxygen Platform, is designed to provide real-time data on tissue oxygen levels, which can be crucial for various medical applications including telehealth and remote patient monitoring.
Profusa has garnered significant attention and support, including backing from DARPA for studies utilizing their technology. The company has also achieved notable milestones such as receiving the CE Mark for its latest generation wireless device. Profusa's innovative approach has the potential to significantly impact healthcare by enabling more precise and timely medical interventions, thereby improving patient outcomes and overall health management.
